iShares Biotechnology ETF Rating $202.64 -2.85 (-1.39%) Closing price 04:00 PM EasternExtended Trading$202.88 +0.24 (+0.12%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsSEC FilingsShort Interest iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.70Holdings in IBB have an aggregate rating of Moderate Buy based on 531 analyst ratings issued in the past year covering 25 companies (67.0% of the portfolio).IBB Aggregate Price Target$202.660.01% UpsideHigh Prediction$202.66Average Prediction$202.66Low Prediction$202.66Holdings in IBB have an aggregate price target of $202.66 and a range of $202.66 to $202.66 covering 25 companies (67.0% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.53%AMGNAmgen$382.47-2.2%3.8769 of 5 stars2.33$381.68 -0.2%30Trending NewsAnalyst ForecastOptions Volume8.04%VRTXVertex Pharmaceuticals$514.56-1.3%3.6325 of 5 stars2.96$569.52 10.7%237.20%GILDGilead Sciences$144.81-0.6%3.9003 of 5 stars2.86$158.78 9.6%29Analyst Forecast5.70%REGNRegeneron Pharmaceuticals$793.26-1.8%4.0447 of 5 stars2.58$802.18 1.1%24Trending NewsAnalyst Forecast3.78%ARGXargenex$984.04-1.8%4.5607 of 5 stars2.88$1,158.61 17.7%243.57%MRNAModerna$136.62+0.7%1.4419 of 5 stars2.08$76.72 -43.8%243.17%NTRANatera$326.14-1.3%2.4856 of 5 stars2.83$330.83 1.4%23Analyst Forecast2.82%RVMDRevolution Medicines$203.35-2.1%2.1367 of 5 stars2.96$210.70 3.6%23Analyst Forecast2.31%ILMNIllumina$201.27-1.8%2.2183 of 5 stars2.44$199.13 -1.1%18Analyst Forecast2.27%BIIBBiogen$215.43+2.2%3.6227 of 5 stars2.58$230.14 6.8%33Positive NewsAnalyst Forecast2.24%ALNYAlnylam Pharmaceuticals$247.51-4.1%4.566 of 5 stars2.88$382.96 54.7%25Analyst Forecast2.08%ONCBeOne Medicines$341.80-2.6%4.4141 of 5 stars3.00$402.71 17.8%17Analyst ForecastHigh Trading Volume1.81%INSMInsmed$127.28-1.2%3.6714 of 5 stars3.00$205.52 61.5%25Positive News1.75%INCYIncyte$123.28-2.2%3.5903 of 5 stars2.54$124.05 0.6%24Positive News1.50%UTHRUnited Therapeutics$503.86-0.6%4.6107 of 5 stars2.85$646.00 28.2%13Insider Trade1.27%ROIVRoivant Sciences$40.94-2.1%2.082 of 5 stars2.85$40.63 -0.8%13Analyst ForecastOptions Volume1.23%GMABGenmab A/S$32.23-2.5%3.9126 of 5 stars2.85$39.50 22.6%13Positive News1.09%ASNDAscendis Pharma A/S$261.23+0.2%4.2982 of 5 stars3.05$310.00 18.7%20Analyst ForecastInsider Trade1.08%NBIXNeurocrine Biosciences$156.57+0.9%4.9191 of 5 stars2.88$201.05 28.4%24Positive NewsAnalyst Forecast0.99%CRLCharles River Laboratories International$272.68-2.0%1.9636 of 5 stars2.67$259.44 -4.9%150.98%MEDPMedpace$583.16-0.5%3.3411 of 5 stars2.25$595.20 2.1%12Positive News0.94%EXELExelixis$57.43-1.5%3.0674 of 5 stars2.35$50.07 -12.8%20Positive NewsAnalyst Revision0.92%BBIOBridgeBio Pharma$72.50-4.7%3.3585 of 5 stars2.83$101.53 40.0%23Trending NewsAnalyst Forecast0.88%BMRNBioMarin Pharmaceutical$65.51+1.7%4.8169 of 5 stars2.74$89.17 36.1%23Analyst Forecast0.88%HALOHalozyme Therapeutics$107.00-0.4%3.3751 of 5 stars2.62$91.20 -14.8%13 This page (NASDAQ:IBB) was last updated on 9/10/2026 by MarketBeat.com Staff. From Our Partners“Elon’s nightmare” could fund your retirementMarc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredThis sub-5 dollar stock operates next to SpaceX and Blue OriginA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...Freedom Financial | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts